Lorcaserin HCl

Alias: APD 356; Lorcaserin hydrochloride; Belviq Xr; Lorcaserin HCl; APD-356; APD356; Lorqess
Cat No.:V1032 Purity: ≥98%
Lorcaserin HCl (Belviq Xr; APD-356; APD356; Lorqess), the hydrochloride salt of Lorcaserin which is a marketed weight-loss drug, is a potent and selective full agonist of human 5-HT2C (serotonin) receptor with Ki of 15 nM.
Lorcaserin HCl Chemical Structure CAS No.: 846589-98-8
Product category: 5-HT Receptor
This product is for research use only, not for human use. We do not sell to patients.
Size Price Stock Qty
10mg
25mg
50mg
100mg
250mg
500mg
Other Sizes
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text

 

  • Business Relationship with 5000+ Clients Globally
  • Major Universities, Research Institutions, Biotech & Pharma
  • Citations by Top Journals: Nature, Cell, Science, etc.
Top Publications Citing lnvivochem Products
Purity & Quality Control Documentation

Purity: ≥98%

Product Description

Lorcaserin HCl (Belviq Xr; APD-356; APD356; Lorqess), the hydrochloride salt of Lorcaserin which is a marketed weight-loss drug, is a potent and selective full agonist of human 5-HT2C (serotonin) receptor with Ki of 15 nM. It suppresses appetite by triggering the hypothalamic 5-HT2C receptor, which is known to regulate appetite.

Biological Activity I Assay Protocols (From Reference)
Targets
RAAS
ln Vitro

In vitro activity: Lorcaserin shows greater affinity for human 5-HT2C compared to 5-HT 5-HT2A (7.5-fold selective, Ki=112 nM) and 5-HT 5-HT2B (11.6-fold selective, Ki=174 nM). All three of the human 5-HT2 receptors are active when lorcaserin is present. Lorcaserin is 104 times more potent at human 5-HT2C than at human 5-HT2B (EC50= 943 nM), and it is 18 times more potent at human 5-HT2C (EC50= 9 nM) than at human 5-HT2A (EC50= 168 nM). Human 5-HT2C and 5-HT2B receptors exhibit full agonist activity, while human 5-HT2A receptors exhibit partial agonist activity (100%, 100%, and 75% of the maximal response elicited by serotonin, respectively). When it comes to ligand binding to serotonin, dopamine, and norepinephrine transporters, lorcaserin is not a rival. In rat synaptosomes, lorcaserin does not increase the release of norepinephrine, dopamine, or serotonin at submicromolar concentrations. Lorcaserin weakly blocks the uptake of dopamine (EC50= 12,000 nM), serotonin (EC50= 1400 nM), and norepinephrine (EC50= 2500 nM).


ln Vivo
Lorcaserin produces reduces food intake and body weight gain during the 4-week trial in a dose-dependent manner. Lorcaserin (18 mg/kg) has no effect on rats' back muscle contractions or wet dog shakes, but it dramatically increases penile grooming and resting. In female rats, nicotine self-administration is significantly reduced by lorcaserin short-term administration (0.3125–20 mg/kg). Over the course of two weeks of repeated injections, long-term lorcaserin (0.625 mg/kg) also significantly lowers nicotine self-administration.
Animal Protocol
0.3125-20 mg/kg; injections
Rats
References

[1]. J Pharmacol Exp Ther . 2008 May;325(2):577-87.

[2]. J Pharmacol Exp Ther . 2011 Sep;338(3):890-6.

These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C11H15CL2N
Molecular Weight
232.15
Exact Mass
231.06
CAS #
846589-98-8
Related CAS #
846589-98-8(HCl)
SMILES
C[C@H]1CNCCC2=C1C=C(C=C2)Cl.Cl
InChi Key
ITIHHRMYZPNGRC-QRPNPIFTSA-N
InChi Code
InChI=1S/C11H14ClN.ClH/c1-8-7-13-5-4-9-2-3-10(12)6-11(8)9;/h2-3,6,8,13H,4-5,7H2,1H3;1H/t8-;/m0./s1
Chemical Name
(5R)-7-chloro-5-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine;hydrochloride
Synonyms
APD 356; Lorcaserin hydrochloride; Belviq Xr; Lorcaserin HCl; APD-356; APD356; Lorqess
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
DMSO: 46~100 mg/mL (198.1~109.2 mM)
Water: ~46 mg/mL (~198.1 mM)
Ethanol: ~46 mg/mL (~198.1 mM)
Solubility (In Vivo)
5%DMSO + 40%PEG300 + 5%Tween 80: 5.0mg/ml (5.46mM) (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 4.3076 mL 21.5378 mL 43.0756 mL
5 mM 0.8615 mL 4.3076 mL 8.6151 mL
10 mM 0.4308 mL 2.1538 mL 4.3076 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration mg/mL;

Method for preparing DMSO stock solution mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation:Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Clinical Trial Information
NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT02400359 Active
Recruiting
Drug: Lorcaserin HCl
Drug: Placebo
Obesity
Weight Loss
Beth Israel Deaconess Medical
Center
October 2014 Phase 4
NCT02019264 Completed Drug: Lorcaserin hydrochloride
Drug: Placebo
Obesity
Overweight
Type 2 Diabetes
Eisai Inc. January 24, 2014 Phase 4
NCT02398669 Completed Drug: Lorcaserin hydrochloride Obesity Eisai Inc. March 2015 Phase 1
NCT00829140 Completed Drug: Placebo
Drug: Lorcaserin 10mg BID
Obesity Eisai Inc. November 2008 Phase 1
NCT00395135 Completed Drug: Lorcaserin 10 mg BID
Drug: Matching Placebo BID
Obesity Eisai Inc. November 2006 Phase 3
Biological Data
  • Lorcaserin HCl
    A, short-term dose-effect function of the higher dose range of lorcaserin on nicotine-self-administration (mean ± S.E.M.).J Pharmacol Exp Ther.2011 Sep;338(3):890-6.
  • Lorcaserin HCl
    A, short-term dose-effect function of the lower dose range of lorcaserin on nicotine-self-administration (mean ± S.E.M.).J Pharmacol Exp Ther.2011 Sep;338(3):890-6.
  • Lorcaserin HCl

    A, chronic lorcaserin administration effect on locomotor activity over 2 weeks of treatment averaged over 12 5-min blocks.J Pharmacol Exp Ther.2011 Sep;338(3):890-6.
Contact Us Back to top